CUE
Cue Biopharma Inc

1,385
Mkt Cap
$45.68M
Volume
271,476.00
52W High
$1.75
52W Low
$0.5406
PE Ratio
-1.27
CUE Fundamentals
Price
$0.5408
Prev Close
$0.5802
Open
$0.59
50D MA
$0.7307
Beta
1.34
Avg. Volume
270,786.52
EPS (Annual)
-$0.7221
P/B
3.41
Rev/Employee
$226,512.20
Loading...
Loading...
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
41

Frequently Asked Questions

What is Market Cap of Cue Biopharma Inc?
What is the 52-week high for Cue Biopharma Inc?
What is the 52-week low for Cue Biopharma Inc?
What is Cue Biopharma Inc stock price today?
What was Cue Biopharma Inc stock price yesterday?
What is the PE ratio of Cue Biopharma Inc?
What is the Price-to-Book ratio of Cue Biopharma Inc?
What is the 50-day moving average of Cue Biopharma Inc?
How many employess does Cue Biopharma Inc has?

Latest CUE News

View

Advertisement|Remove ads.

Advertisement|Remove ads.